| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 07/10/2003 | CA2471306A1 Secreted proteins |
| 07/10/2003 | CA2471297A1 Human netrin receptor and uses thereof |
| 07/10/2003 | CA2471130A1 Il-17 like molecules and uses thereof |
| 07/10/2003 | CA2471042A1 Expression vectors and promoters for heterologous gene expression |
| 07/10/2003 | CA2470903A1 A system for stable expression of sirnas in mammalian cells |
| 07/10/2003 | CA2470781A1 Cystine-knot fold protein |
| 07/10/2003 | CA2470666A1 Secreted protein |
| 07/10/2003 | CA2469690A1 Beta-amyloid binding factors and inhibitors thereof |
| 07/10/2003 | CA2468619A1 Adiponectin fragments and conjugates |
| 07/10/2003 | CA2458751A1 Compositions and methods for the treatement of immune related diseases |
| 07/10/2003 | CA2457801A1 Streptococcus thermophilus strain and use thereof |
| 07/09/2003 | EP1325959A1 Transformation system of fungus belonging to the genus monascus |
| 07/09/2003 | EP1325954A1 An inhibitor of arthropod chitin synthase |
| 07/09/2003 | EP1325930A1 Mammal prolactin variants |
| 07/09/2003 | EP1325929A2 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants |
| 07/09/2003 | EP1325338A2 Diagnosis and treatment of alzheimer's disease |
| 07/09/2003 | EP1325146A2 Process for preparing optically active 4-hydroxy-2-pyrrolidinone and n-substituted 4-hydroxy-2-pyrrolidinones by enzymatic hydroxylation |
| 07/09/2003 | EP1325137A2 Truncated phosphodiesterase-7 polypeptides |
| 07/09/2003 | EP1325135A2 Feedback-resistant pyruvate carboxylase gene from corynebacterium |
| 07/09/2003 | EP1325134A2 Method to alter sugar moieties |
| 07/09/2003 | EP1325133A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 07/09/2003 | EP1325130A2 Nogo receptor homologs |
| 07/09/2003 | EP1325128A2 Lipocalins |
| 07/09/2003 | EP1325126A2 Human ion-exchanger proteins and polynucleotides encoding the same |
| 07/09/2003 | EP1325125A2 Chromosome 3p21.3 genes are tumor suppressors |
| 07/09/2003 | EP1325117A2 Lipid metabolism enzymes |
| 07/09/2003 | EP1325115A2 Cytokine receptor zcytor17 |
| 07/09/2003 | EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 07/09/2003 | EP1325030A2 Genes isolated from dendritic cells, gene products and methods employing the same |
| 07/09/2003 | EP1325027A2 Casein peptide fragments with growth-influencing activity on cell cultures |
| 07/09/2003 | EP1325024A1 Selective growth media |
| 07/09/2003 | EP1325021A1 12 human secreted proteins |
| 07/09/2003 | EP1325020A1 21 human secreted proteins |
| 07/09/2003 | EP1324980A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 07/09/2003 | EP1324768A2 Vaccines for proliferative ileitis |
| 07/09/2003 | EP1071752B1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 07/09/2003 | EP0939831B1 Novel bacterial strains and use thereof in fermentation processes for 2-keto-l-gulonic acid production |
| 07/09/2003 | EP0781843B1 Novel strain of the yeast candida sake (saito and ota) van uden and buckley and its use as biological control agent in fungal diseases of postharversted fruits |
| 07/09/2003 | CN1429276A Modulating production of pneumococcal capsular polysaccharide |
| 07/09/2003 | CN1429273A Protection against environmental toxicity through manipulation of processing of messenger RNA precursors |
| 07/09/2003 | CN1429269A Receptors for hypersensitive response elicitors and uses thereof |
| 07/09/2003 | CN1429268A Novel deoxyribonucleside kinase enzyme multi-substrate variants |
| 07/09/2003 | CN1429115A Adsorbent for endocrine disruptors and foods and drinks containing the same |
| 07/09/2003 | CN1428432A Yeast model for screening insect chitin synthetase inhibitor, its construction method and application |
| 07/09/2003 | CN1428426A Programmed cell death induction molecule II |
| 07/09/2003 | CN1428424A Preparation method of glutaryl-7-aminocefaphytanic acid acyltransferase |
| 07/09/2003 | CN1428417A Miroorganism for over-producing 5'-xanthylic acid |
| 07/09/2003 | CN1428416A Malate-lactic acid bacteria SD-2a and its application |
| 07/09/2003 | CN1428415A Aspergillus niger capable of producing acidic beta-mannase and its fermentation and method for producing manno-oligose |
| 07/09/2003 | CN1428352A Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 07/09/2003 | CN1428174A Waterless cooling, all heat recovering and high-temp. continuous sterilization process |
| 07/09/2003 | CN1113891C Anti-tumour antibiotic and microbiological formentation production method |
| 07/09/2003 | CN1113604C Use of streptomyces WYEC 108 to control plant pathogens |
| 07/09/2003 | CN1113594C Method for producing health-care nutritive mushroom food |
| 07/08/2003 | US6590089 Isolated cDNA encoding a protein of given amino acid sequence; use in diagnosis and treatment of cell proliferative disorders (cancer) and autoimmune disorders |
| 07/08/2003 | US6590078 DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi |
| 07/08/2003 | US6590077 Polypeptide, of given sequence, which stimulates increased growth or altered cell morphology in cells; use in diagnosis, treatment, and prevention of autoimmune/inflammatory, cell proliferative, and vesicle trafficking disorders |
| 07/08/2003 | US6590076 Isolated polypeptide, of given sequence, comprising at least an immunogenic portion of a tumor antigen; may be used to generate antibodies |
| 07/08/2003 | US6590075 Secreted protein HODAZ50 |
| 07/08/2003 | US6589968 Epothilone compounds and methods for making and using the same |
| 07/08/2003 | US6589935 Insulin receptor tyrosine kinase substrate |
| 07/08/2003 | US6589786 Stem cells; cancer; electroporation; cell size; dielectric membrane; Use in the selection, purification, and/or purging of desired (stem) or undesired (cancer) cells from cell suspensions |
| 07/08/2003 | US6589785 Disrupting cells and/or tissue in solid state in presence of solid denaturing substance |
| 07/08/2003 | US6589777 Use to prepare enantiomerically pure precursor material for sertraline synthesis - "(4S) tetralone" or 4-(3,4-dichloro-phenyl)-3,4-dihydro-1(2H)-naphthalenone and for subsequent use in preparation of antidepressant and anorectic agents |
| 07/08/2003 | US6589775 Use in producing clavulanic acid from a transformed, non-clavulanate-producing streptomyces as well as enhanced production from a clavulanate-producing streptomyces transformed using an isolated DNA recombinant vector |
| 07/08/2003 | US6589773 Hexose transporter genes (HXT); pleiotropic drug resistance genes (PDR); gene expression; genetic engineering; promoters; Use in high-throughput screening of compounds that modulate macromolecular interactions |
| 07/08/2003 | US6589772 Iron oxidation; acid tolerance; potential source for novel enzymes; use in providing a biological platform for genetic engineering of organisms which can thrive in hostile environments |
| 07/08/2003 | US6589771 Methods for arousing dormant bacteria |
| 07/08/2003 | US6589769 Method for cloning and expression of TspRI restriction endonuclease and TspRI methylase in E. coli |
| 07/08/2003 | US6589767 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 07/08/2003 | US6589732 Transducing phages |
| 07/08/2003 | US6589725 Adding candidate drug to a cell comprising a recombinant nucleic acid encoding the protein and determining its effect on cell proliferation and viability; drug screening |
| 07/08/2003 | US6589530 Hepatitis B surface antigen vaccine |
| 07/08/2003 | US6589529 Recombinant fusion proteins as immunogens; VP6 protein or carboxy- terminal fragment |
| 07/08/2003 | CA2263883C Kuz, a novel family of metalloproteases |
| 07/08/2003 | CA2121696C Fingerprinting bacterial strains using repetitive dna sequence amplification |
| 07/08/2003 | CA2100245C Methods and compositions for the expression of biologically active eukaryotic cytochrome p450s in bacteria |
| 07/08/2003 | CA2080920C Cloning by complementation and related processes |
| 07/03/2003 | WO2003054755A2 Vaccine for periodontal disease |
| 07/03/2003 | WO2003054221A1 Imp dehydrogenase and the use of the same for identifying fungicidally active compounds |
| 07/03/2003 | WO2003054216A2 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | WO2003054210A2 Regulated nucleic acid expression system |
| 07/03/2003 | WO2003054207A2 Fermentation process for the preparation of l-amino acids using coryneform bacteria |
| 07/03/2003 | WO2003054206A1 Process for the preparation of l-amino acids using coryneform bacteria |
| 07/03/2003 | WO2003054200A1 Chitosanase and use thereof |
| 07/03/2003 | WO2003054199A2 Phytases and method for producing these phytases |
| 07/03/2003 | WO2003054198A1 Alleles of the glucokinase gene coryneform bacteria |
| 07/03/2003 | WO2003054197A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 07/03/2003 | WO2003054193A2 Raf/ras binding compounds |
| 07/03/2003 | WO2003054190A1 Novel proteins and dnas thereof |
| 07/03/2003 | WO2003054185A1 Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease |
| 07/03/2003 | WO2003054184A1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 07/03/2003 | WO2003054181A2 Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants |
| 07/03/2003 | WO2003054180A1 Modified mek1 and mek2, crystal of a peptide: ligand: cofactor complex containing such modified mek1 or mek2, and methods of use thereof |
| 07/03/2003 | WO2003054179A1 Alleles of the siga gene from coryneform bacteria |
| 07/03/2003 | WO2003054177A2 New glycosyl hydrolases |
| 07/03/2003 | WO2003054170A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 07/03/2003 | WO2003054168A2 Defined competitive exclusion cultures for food borne pathogens |
| 07/03/2003 | WO2003054166A2 Nucleotide polymorphisms associated with osteoarthritis |
| 07/03/2003 | WO2003054163A2 Methods for producing hyaluronan in a recombinant host cell |